Paragonix Technologies is a leading provider of Advanced Organ Preservation devices that safeguard donor organs during the journey between donor and recipient patients. Our FDA-cleared and CE-marked devices incorporate clinically proven and medically trusted cold preservation techniques that allow unprecedented physical and thermal protection to the organ in transit. Every Paragonix AOP device natively integrates with our novel digital app, delivering real-time organ tracking data and monitoring logistics for transplant teams seeking a secure and centralized solution.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/27/23 | $24,000,000 | Series B |
Signet Healthcare Partners | undisclosed |
